Stock SYAB SYNLAB AG
Add to a list
To use this feature you must be a member
Log inSign up

SYNLAB AG Stock Deutsche Boerse AG

Equities

SYAB

DE000A2TSL71

Healthcare Facilities & Services

Market Closed - Deutsche Boerse AG
Other stock markets
 06:18:07 2024-06-12 am EDT 		5-day change 1st Jan Change
11.12 EUR +0.72% Intraday chart for SYNLAB AG +0.36% -2.54%
Jun. 10 After cyber attack: British hospitals urgently need blood donations DP
Jun. 04 Hackers attack laboratory chain Synlab again: 'repercussions' for patients DP

Financials

Sales 2024 * 2.86B 3.09B Sales 2025 * 3.02B 3.27B Capitalization 2.44B 2.64B
Net income 2024 * 81M 87.58M Net income 2025 * 67M 72.44M EV / Sales 2024 * 1.37 x
Net Debt 2024 * 1.47B 1.59B Net Debt 2025 * 1.64B 1.77B EV / Sales 2025 * 1.35 x
P/E ratio 2024 *
30 x
P/E ratio 2025 *
37 x
Employees 27,000
Yield 2024 *
1.85%
Yield 2025 *
1.85%
Free-Float 14.25%
More Fundamentals * Assessed data

Chart SYNLAB AG

Dynamic Chart

Latest news about SYNLAB AG

After cyber attack: British hospitals urgently need blood donations DP
Hackers attack laboratory chain Synlab again: 'repercussions' for patients DP
Hackers attack laboratory chain Synlab again - 'consequences' for patients DP
Purchase offer for de-listing drives Synlab up DP
Transcript : SYNLAB AG, Q1 2024 Earnings Call, May 08, 2024
Laboratory chain Synlab starts the year with lower revenue DP
SYNLAB AG Provides Earnings Guidance for the Year 2024 CI
SYNLAB AG Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Certain Ordinary Bearer Shares of SYNLAB AG are subject to a Lock-Up Agreement Ending on 1-MAY-2024. CI
Synlab’s Italian Unit Gradually Resumes Operations After Cyberattack MT
Synlab Faces Cyber Attack in Italy MT
SYNLAB AG(XTRA:SYAB) dropped from S&P Global BMI Index CI
Tranche Update on SYNLAB AG's Equity Buyback Plan announced on September 22, 2022. CI
Transcript : SYNLAB AG, 2023 Earnings Call, Mar 25, 2024
Laboratory chain Synlab earns significantly less in 2023 - cancels dividend DP
More news

Latest transcript on SYNLAB AG

Logo SYNLAB AG
SYNLAB AG, Q1 2024 Earnings Call, May 08, 2024
More transcripts

Analyst Recommendations on SYNLAB AG

Fitch Keeps Synlab on Rating Watch Negative Amid Cinven Takeover MT
SYNLAB : JP Morgan sticks Neutral ZD
Moody's Withdraws Synlab Rating MT
SYNLAB : Jefferies reiterates its Neutral rating ZD
Fitch Places Synlab on Rating Watch Negative Following Cinven Offer MT
More recommendations

Press releases SYNLAB AG

Cybersecurity Incident at Synnovis in UK EQ
SYNLAB AG: Cinven announces public delisting acquisition offer | Conclusion of Delisting Agreement EQ
WpÜG: Tender Offer / Target company: SYNLAB AG; Bidder: Ephios Bidco GmbH EQ
SYNLAB delivers strong performance in Q1 2024 EQ
SYNLAB : Presentation on the Q1 Financial Report 2024 PU
More press releases

News in other languages on SYNLAB AG

Nach Cyberangriff: Britische Kliniken brauchen dringend Blutspenden
Hacker greifen Laborkette Synlab erneut an: 'Auswirkungen' für Patienten
NACHBÖRSE/XDAX +0,3% auf 18.458 Punkte
Hacker greifen Laborkette Synlab erneut an - 'Auswirkungen' für Patienten
Cybersecurity-Vorfall bei Synnovis in Großbritannien
More news

Quotes and Performance

1 day+0.72%
1 week+0.36%
Current month+1.28%
1 month+8.17%
3 months+0.27%
6 months-2.88%
Current year-2.54%
More quotes

Highs and lows

1 week
11.04
Extreme 11.04
11.12
1 month
10.20
Extreme 10.2
11.14
Current year
10.00
Extreme 10
12.30
1 year
8.02
Extreme 8.02
12.30
3 years
6.69
Extreme 6.69
24.60
5 years
6.69
Extreme 6.69
24.60
10 years
6.69
Extreme 6.69
24.60
More quotes

Managers and Directors - SYNLAB AG

Managers TitleAgeSince
Mathieu Floreani CEO
 Chief Executive Officer 56 21-01-25
Sami Badarani DFI
 Director of Finance/CFO 61 21-01-25
Henrik Andreasen CTO
 Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
David Ebsworth CHM
 Chairman 69 21-01-10
Bartholomäus Wimmer FOU
 Founder 63 97-12-31
Peter Catterall BRD
 Director/Board Member 56 21-01-10
More insiders

Quotes

Date Price Change Volume
24-06-12 11.12 +0.72% 102
24-06-11 11.04 -0.36% 0
24-06-10 11.08 -0.18% 0
24-06-07 11.1 0.00% 0
24-06-06 11.1 +0.18% 0

Delayed Quote Deutsche Boerse AG, June 12, 2024 at 06:18 am EDT

More quotes

Company Profile

Synlab AG is a Germany based clinical laboratory and medical diagnostic services provider. The Company is engaged in laboratory services for human and veterinary medicine, as well as environmental analysis.
Sector
Healthcare Facilities & Services
Calendar
2024-08-07 - Q2 2024 Earnings Call
More about the company

Income Statement Evolution

More financial data

Ratings for SYNLAB AG

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
11.1 EUR
Average target price
14.5 EUR
Spread / Average Target
+30.63%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

1st Jan change Capi.
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-22.07% 7.87B
RADNET, INC. Stock RadNet, Inc.
+77.60% 4.52B
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
+6.76% 2.78B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-49.62% 2B
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-13.10% 1.68B
FLEURY S.A. Stock Fleury S.A.
-20.79% 1.47B
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+16.24% 1.22B
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-44.65% 1.12B
VIJAYA DIAGNOSTIC CENTRE LIMITED Stock Vijaya Diagnostic Centre Limited
+21.64% 993M
Medical & Diagnostic Laboratories
  1. Stock Market
  2. Equities
  3. SYAB Stock
  4. SYAB Stock